Transforming the Future of Healthcare: Our Investment in Abridge

We're excited to announce that WndrCo has joined Abridge’s $300M Series E alongside Andreessen Horowitz, Khosla Ventures, and others.

Healthcare providers are drowning in administrative work, and Abridge is ready to change that. The company’s AI-powered medical scribe platform listens to doctor-patient conversations and generates structured clinical notes in real time with remarkable precision. The result? Healthcare professionals consistently report dramatic reductions in 'pajama time' work, the tedious documentation that follows them home each night.

At the heart of Abridge is its Contextual Reasoning Engine. Custom-trained on vast clinical datasets, the proprietary model understands medical terminology, patient history, and individual physician preferences with nuanced accuracy. Unlike generic transcription tools, Abridge's engine excels in high-stakes healthcare interactions and seamlessly supports over 14 languages, a critical capability for serving diverse patient populations.

The market has responded with enthusiasm. More than 100 healthcare systems, including prestigious institutions like Mayo Clinic, Duke, Kaiser Permanente, and Mount Sinai, have embraced Abridge's technology, 

At WndrCo, we back companies that reimagine how people live and work in the modern world. Abridge embodies that mission, and we’re proud to support them in transforming the healthcare experience for providers and patients alike.  

When doctors spend less time on paperwork and more time with patients, everyone wins.